K. Wirkner et al., Inhibition by adenosine A(2A) receptors of NMDA but not AMPA currents in rat neostriatal neurons, BR J PHARM, 130(2), 2000, pp. 259-269
1 Whole-cell patch clamp experiments were used to investigate the transduct
ion mechanism of adenosine A,, receptors in modulating N-methyl-D-aspartate
(NMDA)-induced currents in rat striatal brain slices. The A(2A) receptor a
gonist 2-p-(2-carboxyethyl)phenethylamino-5'-N-amidoadenosine (CGS 21680) i
nhibited the NMDA, but not the (S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazo
lepropionic acid (AMPA) current in a subset of striatal neurons.
2 Lucifer yellow-filled pipettes in combination with immunostaining of A(2A
) receptors were used to identify CGS 21680-sensitive cells as typical medi
um spiny striatal neurons.
3 Dibutyryl cyclic AMP and the protein kinase A activator Sp-cyclic AMPs, b
ut not the protein kinase A inhibitors Rp-cyclic AMPS or PKI(14-24)amide ab
olished the inhibitory effect of CGS 21680. The phospholipase C inhibitor U
-73122, but not the inactive structural analogue U-73343 also interfered wi
th CGS 21680. The activation of protein kinase C by phorbol 12-myristate 13
-acetate or the blockade of this enzyme by staurosporine did. not alter the
effect of CGS 21680. Heparin, an antagonist of inositol 1,4,5-trisphosphat
e (InsP(3)) and a more efficient buffering of intracellular Ca2+ by BAPTA i
nstead of EGTA in the pipette solution, abolished the CGS 21680-induced inh
ibition.
4 The calmodulin antagonist W-7 and cytochalasin B which enhances actin dep
olymerization also prevented the effect of CGS 21680; the calmodulin kinase
II inhibitors CaM kinase II(281 - 309) and KN-93 but not the inactive stru
ctural analogue KN-92 were also effective. The calcineurin inhibitor deltam
ethrin did not interfere with CGS 21680.
5 It is suggested that the transduction mechanism of A(2A) receptors to inh
ibit NMDA receptor channels is the phospholipase C/InsP(3)/calmodulin and c
almodulin kinase II pathway. The adenylate cyclase/protein kinase A and pho
spholipase C/protein kinase C pathways do not appear to be involved.